Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy
Yu Chen(Inner Mongolia Agricultural University), Quan Cheng(Central South University), Wantao Wu(Central South University), Xisong Liang(Central South University), Peng Luo(Zhujiang Hospital), Nan Zhang(Huazhong University of Science and Technology), Zeyu Wang(Anhui University), Hao Zhang(Northwestern Polytechnical University), Rui Chen(Sun Yat-sen University), Jian Zhang(Zhujiang Hospital), Liyang Zhang(Central South University), Jialin He(Central South University), Zaoqu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yun Peng(Chinese Academy of Sciences), Ziyu Dai(Central South University)
Cited by 14
Related Papers
NF-κB in biology and targeted therapy: new insights and translational implications
|Signal Transduction and Targeted Therapy|2024|1.6k
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
The landscape of aging
|Science China Life Sciences|2022|411